245 related articles for article (PubMed ID: 26273136)
21. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.
Cao Q; Wang Y; Niu Z; Wang C; Wang R; Zhang Z; Chen T; Wang XM; Li Q; Lee VWS; Huang Q; Tan J; Guo M; Wang YM; Zheng G; Yu D; Alexander SI; Wang H; Harris DCH
J Am Soc Nephrol; 2018 Mar; 29(3):961-976. PubMed ID: 29295873
[TBL] [Abstract][Full Text] [Related]
22. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.
Gandolfo MT; Jang HR; Bagnasco SM; Ko GJ; Agreda P; Satpute SR; Crow MT; King LS; Rabb H
Kidney Int; 2009 Oct; 76(7):717-29. PubMed ID: 19625990
[TBL] [Abstract][Full Text] [Related]
23. [Mesenchymal stem cells attenuate acute kidney injury via regulation of natural immune system].
Hu J; Zhang L; Cui S; Zhu F; Li D; Feng Z; Chen X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):235-40. PubMed ID: 29917337
[TBL] [Abstract][Full Text] [Related]
24. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
25. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
26. Loss of clusterin expression worsens renal ischemia-reperfusion injury.
Zhou W; Guan Q; Kwan CC; Chen H; Gleave ME; Nguan CY; Du C
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F568-78. PubMed ID: 20007348
[TBL] [Abstract][Full Text] [Related]
27. The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury.
Huber JM; Tagwerker A; Heininger D; Mayer G; Rosenkranz AR; Eller K
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F451-60. PubMed ID: 19458122
[TBL] [Abstract][Full Text] [Related]
28. Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats.
Ke D; Fang J; Fan L; Chen L
Scand Cardiovasc J; 2015 Feb; 49(1):64-71. PubMed ID: 25580940
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury.
Ascon DB; Lopez-Briones S; Liu M; Ascon M; Savransky V; Colvin RB; Soloski MJ; Rabb H
J Immunol; 2006 Sep; 177(5):3380-7. PubMed ID: 16920979
[TBL] [Abstract][Full Text] [Related]
30. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
[TBL] [Abstract][Full Text] [Related]
31. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
32. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
33. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
Stremska ME; Jose S; Sabapathy V; Huang L; Bajwa A; Kinsey GR; Sharma PR; Mohammad S; Rosin DL; Okusa MD; Sharma R
J Am Soc Nephrol; 2017 Sep; 28(9):2681-2693. PubMed ID: 28539382
[TBL] [Abstract][Full Text] [Related]
34. Adoptive transfer of hepatic stellate cells ameliorates liver ischemia reperfusion injury through enriching regulatory T cells.
Feng M; Wang Q; Wang H; Wang M; Guan W; Lu L
Int Immunopharmacol; 2014 Apr; 19(2):267-74. PubMed ID: 24444778
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice.
Hu H; Jiang W; Xi X; Zou C; Ye Z
Am J Nephrol; 2014; 40(3):215-23. PubMed ID: 25322693
[TBL] [Abstract][Full Text] [Related]
36. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury.
Feng M; Wang Q; Zhang F; Lu L
Int Immunopharmacol; 2012 Jan; 12(1):189-96. PubMed ID: 22155100
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
Chu ZQ; Ji Q
Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.
Gandolfo MT; Jang HR; Bagnasco SM; Ko GJ; Agreda P; Soloski MJ; Crow MT; Rabb H
Transpl Immunol; 2010 May; 23(1-2):45-52. PubMed ID: 20412855
[TBL] [Abstract][Full Text] [Related]
40. The role of Foxp3+ regulatory T cells in kidney transplantation.
Karczewski M; Karczewski J; Kostrzewa A; Wiktorowicz K; Glyda M
Transplant Proc; 2009 Jun; 41(5):1527-9. PubMed ID: 19545671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
